Their CVs were built in senior positions at places like Merck, Glaxo SmithKline, and Novartis. Their portfolio experience covers billions of dollars. And their commitment to us speaks volumes about the validity of our approach. The Med-eMonitor system is the brainchild of Bruce Kehr, a physician, well-versed in patient psychology and renowned in the field of medication noncompliance. But what truly underscores the credibility of his science and application is the reputation of our advisory team. Louis Sherwood served as Merck’s Chief Medical Officer for the U.S. and was responsible for all medical activities in the U.S. market, including the Clinical Development program and Outcomes Research and Management. Dennis Langer served as the former Senior VP, Project and Portfolio Management at Glaxo SmithKline. And Geoffrey Nichol held the positions of Head, Global Medical Marketing Excellence, and Head, Global Project Management, at Novartis. Their rich experience base in the clinical trials area provides us with the knowledge and perspective to optimize our offering. And it gives pharmas and CROs a personal benchmark they can trust.